20th World Congress of Stereotactic and Functional Neurosurgery

03-06 September 2024; Chicago, USA

Jointly provided by Partners for Advancing Clinical Education (PACE) and the World Society for Stereotactic and Functional Neurosurgery

 

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and the World Society for Stereotactic and Functional Neurosurgery. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Education

PACE designates this live activity for a maximum of 33.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit Breakdown  

Each participant should claim only those hours of credit that he/she actually spent in the educational activity.

Day	Maximum Credits
September 3	8.5
September 4	8.25
September 5	7.5
September 6	8.75
Total Credits:	33

Target Audience

This activity is intended for Neurosurgeons, Neurosurgical Residents, Fellows, Scientists, and Trainees caring for patients with Stereotactic and Functional Neurosurgery diseases

Educational Objectives                                                   

Upon completion of this activity, participants should be able to:

• Discuss Recent Research and Clinical Breakthroughs in Neurosurgery.
• Analyze Minimally Invasive Procedures.
• Describe Effective Use of Advanced Neurosurgical Equipment.
• Identify Networking and Collaboration Opportunities within the neurosurgical community.
• Discuss Clinical Challenges and Innovations in the neurology field.

Faculty

The faculty list with titles and affiliations will be provided in due course.

Disclosure of Conflicts of Interest

PACE requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to PACE policies. Others involved in the planning of this activity have no relevant financial relationships.

 

American Board of Internal Medicine Maintenance of Certification

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 33.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

To receive CME credit and/or MOC points, you MUST pass the posttest and complete the evaluation. For ABIM MOC points, your information will be shared with the ABIM through PACE’s Joint Accreditation Program and Activity Reporting System (JAPARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records. By sharing your Diplomate Board ID # and DOB, you are giving PACE permission to use this information/data to report your participation to these Boards JA-PARS.

Disclosure of Unlabeled Use

This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Instructions for Credit

To receive CE credit, please follow these steps:

1. Enter your profile information or create a new account HERE
2. Visit the WSSFN 2024 online evaluation HERE
3. Complete the activity evaluation.
4. Upon completion of all evaluation questions, your credit will be made available for download immediately.

For any questions or concerns, please contact us at: education@kenes.com

Program Agenda 

The agenda with registration and break times is listed HERE.

Americans with Disabilities Act

Event staff will gladly assist you with any special needs (i.e., physical, dietary, etc). Please contact Lucia Herrero prior to the live event at lherrero@kenes.com .

Fee Information

Information regarding the registration fees can be found HERE.